← Back to Search

Digital Memory Notebook for Cognitive Impairment (DMN Trial)

N/A

Waitlist Available

Led By Sarah Farias, PhD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1, week 8, and week 12

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether the Digital Memory Notebook, a tablet-based app, can help older adults with mild cognitive impairment or subjective cognitive complaints complete everyday tasks.

Who is the study for?

This trial is for English-speaking adults aged 60 or older with mild cognitive impairment (MCI) or subjective cognitive complaints (SCC). They must have someone to help with surveys. Pregnant women, those unable to consent, and prisoners are excluded.

What is being tested?

The study tests a Digital Memory Notebook app designed to aid daily tasks for people with memory issues. It involves a 6-week training on using the app followed by a 4-week period of regular use, with assessments before and after the intervention.

What are the potential side effects?

Since this trial involves using an application rather than medication, traditional side effects are not expected. However, participants may experience frustration or difficulty adapting to new technology.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1, week 8, and week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1, week 8, and week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1, week 8, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Real-time data extracted from the DMN Application

Secondary study objectives

Participant Questionnaire Outcomes

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: DMN InterventionExperimental Treatment1 Intervention

Subjects will attend 2-hour weekly sessions for 6- weeks. Participants will continue to use the DMN application for 4-weeks after the intervention is complete.

Do I qualify?Apply below to find out